Diabetes and Immunocompromise: Understanding the Link
Diabetes mellitus is not a primary immunodeficiency, but chronic hyperglycemia causes secondary immune dysfunction, increasing infection risk and impairing wound healing.
Mechanisms
- Neutrophil/Macrophage Impairment: Reduced chemotaxis, phagocytosis, oxidative burst.
- Cytokine Dysregulation: Altered IL‑1, TNF‑α, IFN‑γ signaling disrupts immune coordination.
- Glycation Effects: Advanced glycation end‑products (AGEs) impair collagen cross‑linking and leukocyte function.
- Vascular Complications: Microangiopathy reduces tissue perfusion and leukocyte delivery.
Clinical Consequences
- Higher incidence of skin/soft‑tissue infections, UTIs, pneumonia, tuberculosis.
- Delayed wound healing → chronic ulcers, amputations.
- Type 1 diabetes associates with autoimmune thyroiditis, celiac disease—further immune dysregulation.
Mitigation: Tight glycemic control (HbA1c <7%), routine vaccinations (flu, pneumococcal, hepatitis B, COVID‑19), meticulous foot care, prompt infection treatment, and multidisciplinary management preserve immune competence.
Diabetes - Related Articles
- Where to Get a Blood Glucose Test: Options and Considerations
- Managing Gestational Diabetes: Diet & Nutrition During Pregnancy
- Glucose: The Body's Primary Energy Source - Function & Benefits
- Diabetes Financial Assistance: Navigating Healthcare Costs
- Diamox and Diabetes: Understanding the Risks and Effects
- Fasting for Diabetes Tests: How Long is Required?
- Diabetes Types 1 and 2: Management Strengths and Complication Risks
